Gastroesophageal Varices
18
2
2
1
Key Insights
Highlights
Success Rate
50% trial completion
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 40/100
5.6%
1 terminated out of 18 trials
50.0%
-36.5% vs benchmark
17%
3 trials in Phase 3/4
100%
1 of 1 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 1 completed trials
Clinical Trials (18)
Development of 4D Flow MRI for Risk Stratification of Variceal Bleeding in Cirrhosis
Cirrhotic and Non-cirrhotic Patients With Clinically Significant Portal Hypertension
Timing of Endoscopic Intervention for Acute Variceal Hemorrhage: an RCT
Feasibility and Safety Evaluation of Endoscopic Treatment of Esophagogastric Varices in Cirrhosis on the Day-care Unit
Dual Energy CT as a Noninvasive Method to Screen for Gastroesophageal Varices
Endoscopic Ruler for the Assessment of Variceal Bleeding Risks (CHESS2005)
Endoscopic and Microbiological Assessment of the Effect of Carvedilol Combined With Berberine on GOV in Cirrhosis
MCCE in Assessing Efficacy of Gastro-oesophageal Varices
Risk Prediction of Bleeding in Liver Cirrhosis by Combi-elastography
EUS-guided PSE in Combination With EUS-guided Treatment of Varices for Patients With Portal Hypertension
EUS-guided Glue Injection for Varices Study
Early Diagnosis of Oxaliplatin-induced Portal Hypertension
Anticoagulation in Gastroesophageal Varices and JAK2 Mutation
Gastroesophageal Varices in Cavernoma
Non-invasive Method for Predicting the Presence of Gastroesophageal Varices in Patients With Cirrhosis
Gastric Variceal Ligation Versus Gastric Variceal Obturation for Secondary Prophylaxis of Gastric Varices
Scleroligation for Eradication of Gastroesophageal Varices.
The Effect of Hepatic Vein Pressure Gradient(HVPG)-Guided Therapy in Cirrhotic Patients With Esophagogastric Varices